US Patent Issued to NANJING UNIVERSITY OF CHINESE MEDICINE on Dec. 23 for "(9beta-H)-pimarane mother nucleus diterpenoid compound with anti-colon cancer activity and derivative thereof, and preparation method thereof" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,372, issued on Dec. 23, was assigned to NANJING UNIVERSITY OF CHINESE MEDICINE (Nanjing, China).

"(9beta-H)-pimarane mother nucleus diterpenoid compound with anti-colon cancer activity and derivative thereof, and preparation method thereof" was invented by Ming Zhao (Nanjing, China), Jinao Duan (Nanjing, China), Junfei Zhou (Nanjing, China), Lu Fan (Nanjing, China), Cai Lu (Nanjing, China), Mingming Xu (Nanjing, China), Di Di (Nanjing, China), Sheng Guo (Nanjing, China) and Shulan Su (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention discloses a (9Beta-H)-pimarane skeleton diterpenoids with anti-colon cancer activity and a ...